SiSaf Ltd
SiSaf is a biopharmaceutical company developing RNA therapeutics focused on rare genetic disorders. They use bioabsorbable silicon-based Bio-Courier technology to enhance the delivery of nucleic acids for medical applications.
- RNA therapeutics
- Bio-Courier technology
- siRNA therapies for rare skeletal diseases
- Topical gene therapies for corneal dystrophies
Locations
Digital Popularity
Social Media
LinkedIn1,370 Followers
Competitors
Harness Therapeutics is focused on developing disease-modifying therapies for neurodegenerative diseases through innovative RNA translation methodologies.
Exonate is a biotechnology company dedicated to improving treatment options for patients suffering from retinal vascular diseases.
Orchard Therapeutics is a pioneering biotechnology company focused on developing transformative gene therapies for patients with severe genetic diseases.
Company Details
SiSaf Ltd is operated by Sisaf Ltd and is a Active company incorporated on 23 October 2006 with the registered office located in Guildford, Surrey. Sisaf Ltd was registered 18 years ago.
Status
Active
Size
Unreported
Directors
10
Age
18 years old
Employees
23
Turnover
Unreported
Total Assets
£9.57M
Cash in Bank
£3.17M
Total Liabilities
-£426K
Teams
20
8
7
3
2
2
2
Chairwoman & CEO • Joined Jul 2016
Non Executive Director • Joined Sep 2008
Chief Technical Officer • Joined Jul 2016
Chief Financial Officer • Joined Aug 2019
Chief Marketing Officer
Chief A.I. Officer • Joined Jun 2023
General Manager • Joined Nov 2016
Bioanalytical Development Manager • Joined Aug 2023
EH&S Manager • Joined Jan 2023
Head Of Biomedical Research • Joined Aug 2023
Chairwoman & CEO • Joined Jul 2016
Chief Technical Officer • Joined Jul 2016
Company Secretary • Joined Oct 2008
Head Of Biomedical Research • Joined Aug 2023
R&D Team Leader • Joined Jul 2018
Director, Operations & Business Development
Research & Development Team Leader • Joined Jan 2023
Member Board Of Directors • Joined Apr 2023
Chairwoman & CEO • Joined Jul 2016
Non Executive Director • Joined Sep 2008
Chief Technical Officer • Joined Jul 2016
Chief Financial Officer • Joined Aug 2019
Chief Marketing Officer
General Manager • Joined Nov 2016
Member Board Of Directors • Joined Apr 2023
Head Of Biomedical Research • Joined Aug 2023
Senior Formulation Chemist • Joined Jan 2024
Senior Formulation Scientist • Joined Jan 2022
Chief Financial Officer • Joined Aug 2019
Bookkeeper • Joined Apr 2012
General Manager • Joined Nov 2016
EH&S Manager • Joined Jan 2023
Consultant • Joined May 2021
Analytical Scientist • Joined Sep 2022
View 20 members